Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (27)
Positron emission tomography/computed tomography (PET/CT) (20)
Prostate cancer (14)
SDG-03: Good health and well-being (11)
Nuclear medicine (10)
Prostate-specific membrane antigen (PSMA) (10)
Infection (9)
Tuberculosis (TB) (8)
PET/CT (7)
South Africa (SA) (7)
Human immunodeficiency virus (HIV) (6)
Radiopharmaceuticals (6)
Cancer (5)
Cervical cancer (5)
Coronavirus disease 2019 (COVID-19) (5)
COVID-19 pandemic (5)
Molecular imaging (5)
Antimicrobial peptide (AMP) (4)
Computed tomography (CT) (4)
Fluorodeoxyglucose positron emission tomography (FDG PET) (4)
HIV infection (4)
Prostate carcinoma (4)
Theranostics (4)
[18F]FDG PET/CT (3)
Africa (3)
Bacteria (3)
Biodistribution (3)
Breast cancer (3)
Diagnosis (3)
Invasive fungal infection (IFI) (3)
Patients (3)
Prostate specific membrane antigen (PSMA) (3)
Radioligand therapy (3)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (3)
Ubiquicidin (3)
UCTD (3)
177Lu-PSMA (2)
18F-FDG (2)
18F-FDG PET/CT (2)
18F-fluciclovin PET (2)
18F-fluciclovine PET/CT imaging (2)
68Ga (2)
68Ga-PSMA (2)
68Ga-PSMA PET (2)
[68Ga]Ga-NODAGAZOL (2)
Actinium-225 (2)
Angiogenesis (2)
Anti-tuberculous treatment (ATT) (2)
Arterial inflammation (2)
Biochemical recurrence (BCR) (2)
Bone scan (2)
Case report (2)
Computerized tomography (CT) (2)
Developing countries (2)
Diagnostic imaging (2)
DOTA (2)
FDG PET (2)
Fibroblast activation protein inhibitor (FAPI) (2)
Fluorodeoxyglucose (FDG) (2)
HIV/AIDS (2)
Hypoxia (2)
Immunohistochemistry (2)
In vivo (2)
Infection imaging (2)
Inflammation (2)
Invasive fungal disease (IFD) (2)
Invasive fungal infections (2)
Magnetic resonance imaging (MRI) (2)
Medical imaging (2)
Metabolic tumor volume (MTV) (2)
Metastatic castration-resistant prostate cancer (mCRPC) (2)
Microemulsion (2)
NODAGA (2)
Patient management (2)
Peptide receptor radionuclide therapy (PRRT) (2)
PET imaging (2)
Prevention (2)
Quality control (2)
Radiochemistry (2)
Radiolabeling (2)
Radiotracers (2)
Residual metabolic activity (RMA) (2)
Salvage radiotherapy (SRT) (2)
Scintigraphy (2)
SDG-04: Quality education (2)
Sentinel lymph node (SLN) (2)
Single photon emission computed tomography (SPECT) (2)
Somatropin (2)
SPECT (2)
SPECT/CT (2)
Therapy (2)
Therapy monitoring (2)
Total lesion glycolysis (TLG) (2)
Treatment (2)
Xeroderma pigmentosum (XP) (2)
18 F-fluciclovine PET/CT (1)
18 F-rhPSMA PET/CT (1)
18F- (1)
18F-FDG imaging (1)
18F-fluorodeoxyglucose (18F-FDG) (1)